1Argatoff LH, Connors JM, Klasa R J, et al. Mantle cell lymphoma : a clinicopathologic study of 80 cases[ J]. Blood, 1997, 89(6) : 2067-2078.
2Bernard M, Gressin R, Lefrare F, et al. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype [ J ]. Leukemia, 2001, 15 ( 11 ) : 1785-1791.
3Roty R, Franssila K, Jansson SE, et al. Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma [ J ]. Eur J Cancer, 2003, 39(3):321-329.
4Romaguera JE, Fayad LE, Feng L, et al. Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine ( R- MA ) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma [ J ]. Br J Haematol, 2010. 150(2) :200-208.
5Garcia-Noblejas A, Martinez Chamorro C, Navarro Matilla B, et al. Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experience [ J ]. Ann Hematol, 2014, 93 (9) : 1551- 1558.
